Macrolide Drugs Market Size, Share, Trends, Growth and Forecast 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Macrolide Drugs market, 2015 - 2024 (USD Billion)
  • 2.2. Global Macrolide Drugs market : Snapshot
•  
• Chapter 3. Macrolide Drugs market- Market Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Macrolide Drugs market drivers: Impact analysis
    • 3.2.2. Increasing incidences of cancer
    • 3.2.3. Increasing geriatric population
  • 3.3. Market Restraints
    • 3.3.1. Global Macrolide Drugs market restraints: Impact analysis
    • 3.3.2. Lack of infrastructure
  • 3.4. Opportunities
    • 3.4.1. Technological advancements in Macrolide Drugs market Types
  • 3.5. Porter's five forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat from new entrants
    • 3.5.4. Threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Type segment
    • 3.6.2. Market attractiveness analysis, by sales channel segment
    • 3.6.3. Market attractiveness analysis, by regional segment
•  
• Chapter 4. Global Macrolide Drugs market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Macrolide Drugs market: company market share, 2015
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Type Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development, Regional Expansion
•  
• Chapter 5. Global Macrolide Drugs market - Type Segment Analysis
  • 5.1. Global Macrolide Drugs market: Type overview
    • 5.1.1. Global Macrolide Drugs market revenue share, by Type, 2015 and 2024
  • 5.2. 14-membered ring agents
    • 5.2.1. Global 14-membered ring agents market, 2015 - 2024(USD Billion)
  • 5.3. 15-membered ring agents (Azalides)
    • 5.3.1. Global 15-membered ring agents (Azalides) market, 2015 - 2024(USD Billion)
  • 5.4. 16-membered ring agents
    • 5.4.1. Global 16-membered ring agents market, 2015 - 2024(USD Billion)
  • 5.5. Ketolides
    • 5.5.1. Global Ketolides market, 2015 - 2024(USD Billion)
•  
• Chapter 6. Global Macrolide Drugs market -Sales Channel Segment Analysis
  • 6.1. Global Macrolide Drugs market: Sales Channel overview
    • 6.1.1. Global Macrolide Drugs market revenue share, by sales channel, 2015 and 2022
  • 6.2. Hospital pharmacies
    • 6.2.1. Global Hospital pharmacies market, 2015 - 2024(USD Billion)
  • 6.3. Clinics
    • 6.3.1. Global Clinics market, 2015 - 2024(USD Billion)
  • 6.4. Hospitals
    • 6.4.1. Global Hospitals market, 2015 - 2024(USD Billion)
  • 6.5. Retail pharmacies
    • 6.5.1. Global Retail pharmacies market, 2015 - 2024(USD Billion)
  • 6.6. Online pharmacies
    • 6.6.1. Global Online pharmacies market, 2015 - 2024(USD Billion)
•  
• Chapter 7. Global Macrolide Drugs market - Regional Segment Analysis
  • 7.1. Global Macrolide Drugs market: Regional overview
    • 7.1.1. Global Macrolide Drugs market revenue share, by region, 2015 and 2021
  • 7.2. North America
    • 7.2.1. North America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    • 7.2.2. North America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.2.3. U.S.
      • 7.2.3.1. U.S. Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.2.3.2. U.S. Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.2.4. Canada
      • 7.2.4.1. Canada Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.2.4.2. Canada Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.2.5. Rest of North America
      • 7.2.5.1. Rest of North America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.2.5.2. Rest of North America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    • 7.3.2. Europe Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.3.3.2. Germany Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.3.4. U.K.
      • 7.3.4.1. U.K. Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.3.4.2. U.K. Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.3.5. France
      • 7.3.5.1. France Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.3.5.2. France Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.3.6. Italy
      • 7.3.6.1. Italy Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.3.6.2. Italy Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.3.7. Spain
      • 7.3.7.1. Spain Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.3.7.2. Spain Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.3.8. Russia
      • 7.3.8.1. Russia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.3.8.2. Russia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.3.9. Rest of Europe
      • 7.3.9.1. Rest of Europe Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.3.9.2. Rest of Europe Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    • 7.4.2. Asia Pacific Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.4.3. China
      • 7.4.3.1. China Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.4.3.2. China Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.4.4. Japan
      • 7.4.4.1. Japan Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.4.4.2. Japan Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.4.5. India
      • 7.4.5.1. India Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.4.5.2. India Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.4.6.2. Australia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
    • 7.5.2. Latin America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.5.3.2. Mexico Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.5.4. Brazil
      • 7.5.4.1. Brazil Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.5.4.2. Brazil Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.5.5. Argentina
      • 7.5.5.1. Argentina Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.5.5.2. Argentina Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.5.6. Rest of Latin America
      • 7.5.6.1. Rest of Latin America Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.5.6.2. Rest of Latin America Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Macrolide Drugs market revenue, by Type, 2015 - 2024(USD Billion)
    • 7.6.2. Middle East and Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.6.3.2. Saudi Arabia Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.6.4.2. UAE Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.6.5. Qatar
      • 7.6.5.1. Qatar Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.6.5.2. Qatar Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.6.6. South Africa
      • 7.6.6.1. South Africa Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.6.6.2. South Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
    • 7.6.7. Rest of Middle East & Africa
      • 7.6.7.1. Middle East & Africa Macrolide Drugs market revenue, by type, 2015 - 2024(USD Billion)
      • 7.6.7.2. Middle East & Africa Macrolide Drugs market revenue, by sales channel, 2015 - 2024(USD Billion)
•  
• Chapter 8. Company Profile
  • 8.1. Abbott Laboratories
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Therapy portfolio
    • 8.1.4. Business strategy
    • 8.1.5. Recent developments
  • 8.2. Akorn, Inc.
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Therapy portfolio
    • 8.2.4. Business strategy
    • 8.2.5. Recent developments
  • 8.3. Eli Lilly & Co.
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Therapy portfolio
    • 8.3.4. Business strategy
    • 8.3.5. Recent developments
  • 8.4. Fresenius Kabi USA
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Therapy portfolio
    • 8.4.4. Business strategy
    • 8.4.5. Recent developments
  • 8.5. Gland Pharma Limited
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Therapy portfolio
    • 8.5.4. Business strategy
    • 8.5.5. Recent developments
  • 8.6. Macrolide Pharmaceuticals
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Therapy portfolio
    • 8.6.4. Business strategy
    • 8.6.5. Recent developments
  • 8.7. Neo Química
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Therapy portfolio
    • 8.7.4. Business strategy
    • 8.7.5. Recent developments
  • 8.8. Mylan N.V.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Therapy portfolio
    • 8.8.4. Business strategy
    • 8.8.5. Recent developments
  • 8.9. Pfizer, Inc.
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Therapy portfolio
    • 8.9.4. Business strategy
    • 8.9.5. Recent developments
  • 8.10. Merck & Co.
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Therapy portfolio
    • 8.10.4. Business strategy
    • 8.10.5. Recent developments
  • 8.11. Merck & Co.
    • 8.11.1. Overview
    • 8.11.2. Financials
    • 8.11.3. Therapy portfolio
    • 8.11.4. Business strategy
    • 8.11.5. Recent developments
  • 8.12. Sandoz International GmbH
    • 8.12.1. Overview
    • 8.12.2. Financials
    • 8.12.3. Therapy portfolio
    • 8.12.4. Business strategy
    • 8.12.5. Recent developments
  • 8.13. Teva Pharmaceutical Industries Ltd.
    • 8.13.1. Overview
    • 8.13.2. Financials
    • 8.13.3. Therapy portfolio
    • 8.13.4. Business strategy
    • 8.13.5. Recent developments
  • 8.14. WOCKHARDT
    • 8.14.1. Overview
    • 8.14.2. Financials
    • 8.14.3. Therapy portfolio
    • 8.14.4. Business strategy
    • 8.14.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Macrolide Drugs market revenue, 2015 – 2024 (USD Billion) 
4. Porter’s five forces analysis
5. Macrolide Drugs market attractiveness analysis, by type segment
6. Macrolide Drugs market: Market attractiveness analysis, by sales channel segment
7. Macrolide Drugs market: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015 
9. Global Macrolide Drugs market revenue share by Type, 2015 and 2024
10.  Global 14-membered ring agents market, 2015 – 2024 (USD Billion)
11. Global 15-membered ring agents (Azalides) market, 2015 – 2024 (USD Billion)
12. Global 16-membered ring agents market, 2015 – 2024 (USD Billion)
13. Global Ketolides market, 2015 – 2024 (USD Billion)
14.  Global Macrolide Drugs market revenue share by sales channel, 2015 and 2024
15.  Global Macrolide Drugs market for Hospital pharmacies, 2015 – 2024, (USD Billion) 
16.  Global Macrolide Drugs market for Clinics, 2015 – 2024, (USD Billion) 
17. Global Macrolide Drugs market for Hospitals, 2015 – 2024, (USD Billion)
18. Global Macrolide Drugs market for Retail pharmacies, 2015 – 2024, (USD Billion)

Table Of Tables

List of Tables

1. Macrolide Drugs market: Market Snapshot                                                           
2. Drivers of global Macrolide Drugs market: Impact analysis 
3. Restraints of global Macrolide Drugs market: Impact analysis  
4. North America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
5. North America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
6. U.S. Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
7. U.S. Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
8. Canada Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
9. Canada Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
10. Rest of North America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
11. Rest of North America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
12. Europe Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
13. Europe Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
14. Germany Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
15. Germany Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
16. France Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
17. France Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
18. U.K. Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
19. U.K. Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
20. Italy Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
21. Italy Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
22. Spain Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
23. Spain Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
24. Russia Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
25. Russia Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
26. Rest of Europe Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
27. Rest of Europe Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
28. Asia Pacific Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
29. Asia Pacific Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
30. China Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
31. China Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
32. Japan Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
33. Japan Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
34. India Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
35. India Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
36. Australia Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
37. Australia Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion) India Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
38. Rest of Asia Pacific Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
39. Rest of Asia Pacific America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
40. Latin America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
41. Mexico Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
42. Mexico Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
43. Brazil Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
44. Brazil Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
45. Argentina Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
46. Argentina Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
47. Rest of Latin America Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
48. Rest of Latin America Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
49. Middle East and Africa Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
50. Middle East and Africa Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
51. Saudi Arabia Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
52. Saudi Arabia Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
53. UAE Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
54. UAE Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
55. Qatar Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
56. Qatar Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
57. South Africa Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
58. South Africa Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)
59. Rest of Middle East and Africa Macrolide Drugs market revenue, by Type, 2015 – 2024(USD Billion) 
60. Rest of Middle East and Africa Macrolide Drugs market revenue, by sales channel, 2015 – 2024(USD Billion)